ATE435225T1 - Oxadiazolonderivate als ppar-delta-agonisten - Google Patents
Oxadiazolonderivate als ppar-delta-agonistenInfo
- Publication number
- ATE435225T1 ATE435225T1 AT05716233T AT05716233T ATE435225T1 AT E435225 T1 ATE435225 T1 AT E435225T1 AT 05716233 T AT05716233 T AT 05716233T AT 05716233 T AT05716233 T AT 05716233T AT E435225 T1 ATE435225 T1 AT E435225T1
- Authority
- AT
- Austria
- Prior art keywords
- ppar
- delta agonists
- oxadiazolone derivatives
- oxadiazolone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04007879A EP1586573B1 (de) | 2004-04-01 | 2004-04-01 | Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika |
| PCT/EP2005/002950 WO2005097786A1 (en) | 2004-04-01 | 2005-03-19 | Oxadiazolone derivatives as ppar delta agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435225T1 true ATE435225T1 (de) | 2009-07-15 |
Family
ID=34924545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05716233T ATE435225T1 (de) | 2004-04-01 | 2005-03-19 | Oxadiazolonderivate als ppar-delta-agonisten |
Country Status (38)
| Country | Link |
|---|---|
| US (3) | US20070179191A1 (de) |
| EP (3) | EP1586573B1 (de) |
| JP (1) | JP2007530612A (de) |
| KR (1) | KR20060135857A (de) |
| CN (1) | CN100582104C (de) |
| AR (1) | AR050576A1 (de) |
| AT (1) | ATE435225T1 (de) |
| AU (1) | AU2005231916A1 (de) |
| BR (1) | BRPI0509517A (de) |
| CA (1) | CA2561627A1 (de) |
| CR (1) | CR8572A (de) |
| CY (1) | CY1109370T1 (de) |
| DE (2) | DE602004004631D1 (de) |
| DK (1) | DK1740583T3 (de) |
| DO (1) | DOP2005000051A (de) |
| EC (1) | ECSP066892A (de) |
| ES (1) | ES2329484T3 (de) |
| GT (1) | GT200500028A (de) |
| HK (1) | HK1100408A1 (de) |
| HR (1) | HRP20090493T1 (de) |
| IL (1) | IL178056A0 (de) |
| MA (1) | MA28495B1 (de) |
| MY (1) | MY142431A (de) |
| NO (1) | NO20064981L (de) |
| PA (1) | PA8628701A1 (de) |
| PE (1) | PE20060323A1 (de) |
| PL (1) | PL1740583T3 (de) |
| PT (1) | PT1740583E (de) |
| RS (1) | RS51186B (de) |
| RU (1) | RU2374243C2 (de) |
| SI (1) | SI1740583T1 (de) |
| SV (1) | SV2006002071A (de) |
| TN (1) | TNSN06317A1 (de) |
| TW (1) | TW200602342A (de) |
| UA (1) | UA84203C2 (de) |
| UY (1) | UY28837A1 (de) |
| WO (1) | WO2005097786A1 (de) |
| ZA (1) | ZA200606870B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060017929A (ko) * | 2004-08-04 | 2006-02-28 | 동화약품공업주식회사 | 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물 |
| JP2009509988A (ja) | 2005-09-29 | 2009-03-12 | サノフィ−アベンティス | フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用 |
| EP1931659B1 (de) | 2005-09-29 | 2010-09-08 | Sanofi-Aventis | Derivate von 2-aminthiazolen und 2-aminooxazolen, verfahren zu deren darstellung und deren verwendung als arzneimittel |
| EP1931660B1 (de) * | 2005-09-29 | 2012-08-01 | Sanofi | Phenyl-[1,2,4]-oxadiazol-5-on-derivate mit phenylgruppe, verfahren zu deren darstellung und deren verwendung als arzneimittel |
| JP2010502719A (ja) | 2006-09-08 | 2010-01-28 | ロード アイランド ホスピタル | アルコール誘発性脳疾患の治療、予防および回復 |
| JP5864077B2 (ja) | 2006-09-08 | 2016-02-17 | ロード アイランド ホスピタル | アルコール誘発性肝疾患の治療、予防および回復 |
| EP1932843A1 (de) * | 2006-12-14 | 2008-06-18 | sanofi-aventis | Sulfonyl-Phenyl-2H-(1,2,4) Oxadiazol-5-one-Derivate, Verfahren zur Herstellung dafür und zur pharmazeutischen Verwendung damit |
| EP2288605B1 (de) * | 2008-06-09 | 2014-06-25 | Sanofi | Annelierte pyrrolidinsulfonamide mit einer oxadiazolon-kopfgruppe, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika |
| WO2010000353A1 (en) * | 2008-06-09 | 2010-01-07 | Sanofi-Aventis | Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| US8329725B2 (en) | 2008-06-09 | 2012-12-11 | Sanofi | Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| WO2010042212A2 (en) | 2008-10-10 | 2010-04-15 | Dara Biosciences, Inc. | Methods for treating or preventing pain using spicamycin derivatives |
| LT3135672T (lt) * | 2008-10-10 | 2020-05-25 | Vm Discovery, Inc. | Kompozicijos ir būdai skirti gydyti alkoholio vartojimo sutrikimus, skausmą ir kitas ligas |
| AU2010279964B2 (en) * | 2009-08-05 | 2016-02-11 | Daiichi Sankyo Company, Limited | Amide derivative |
| JP5546543B2 (ja) * | 2009-08-05 | 2014-07-09 | 第一三共株式会社 | スルホン誘導体 |
| WO2015061481A1 (en) | 2013-10-23 | 2015-04-30 | Dara Biosciences, Inc. | Methods of treating liquid tumors using compositions comprising spicamycin derivatives |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256680A (en) * | 1988-11-29 | 1993-10-26 | Warner-Lambert Company | 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents |
| FR2663336B1 (fr) | 1990-06-18 | 1992-09-04 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
| ZA941003B (en) | 1993-02-15 | 1995-08-14 | Wellcome Found | Hypolipidaemic compounds |
| US5641796A (en) * | 1994-11-01 | 1997-06-24 | Eli Lilly And Company | Oral hypoglycemic agents |
| JP3144624B2 (ja) | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| BR9707003A (pt) | 1996-01-17 | 1999-07-20 | Novo Nordisk As | Composto processos para preparar o mesmo para tratamento ou de prevenção de doenças do sistema endócrino e para a manufatura de medicamento coposção farmacêutica e utilização de um composto |
| BRPI9711437B8 (pt) | 1996-08-30 | 2021-05-25 | Novo Nordisk As | derivados de glp-1 |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| IL142649A (en) | 1996-12-31 | 2004-12-15 | Reddy Research Foundation | Azole derivatives |
| DE19726167B4 (de) | 1997-06-20 | 2008-01-24 | Sanofi-Aventis Deutschland Gmbh | Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung |
| EP1000066A1 (de) | 1997-07-16 | 2000-05-17 | Novo Nordisk A/S | Kondensierte 1,2,4-thiadiazinderivate, ihre herstellung und verwendung |
| CO4970713A1 (es) | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
| DE19823831A1 (de) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| MA26634A1 (fr) | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| SE9801992D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| US6221897B1 (en) | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| DE19828114A1 (de) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
| DE19828113A1 (de) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
| DE19845405C2 (de) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
| DE19916108C1 (de) | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
| AU3956900A (en) | 1999-04-16 | 2000-11-02 | Boehringer Ingelheim International Gmbh | Substituted imidazoles, their preparation and use |
| EP1177187B1 (de) | 1999-04-28 | 2007-07-25 | Sanofi-Aventis Deutschland GmbH | Di-aryl-säurederivate als ppar rezeptor liganden |
| CZ20013834A3 (cs) | 1999-04-28 | 2002-04-17 | Aventis Pharma Deutschland Gmbh | Deriváty kyselin se třemi arylovými zbytky jako ligandy receptorů PPAR a farmaceutické prostředky, které je obsahují |
| CA2371271A1 (en) | 1999-04-30 | 2000-11-09 | Neurogen Corporation | 9h-pyrimido[4,5-b]indole derivatives: crf1 specific ligands |
| GB9911863D0 (en) | 1999-05-21 | 1999-07-21 | Knoll Ag | Therapeutic agents |
| CA2376919C (en) | 1999-06-18 | 2008-11-04 | Merck & Co., Inc. | Arylthiazolidinedione and aryloxazolidinedione derivatives |
| GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| EP1196610A2 (de) | 1999-07-09 | 2002-04-17 | Cohesion Technologies, Inc. | Ecarin polypeptide, dafür kodierende polynukleotide und vefahren zur verwendung davon |
| ES2203498T3 (es) | 1999-07-29 | 2004-04-16 | Eli Lilly And Company | Benzofurilpiperazinas: agonistas de receptor 5-ht2c de la serotonina. |
| EE200200095A (et) | 1999-09-01 | 2003-04-15 | Aventis Pharma Deutschland Gmbh | Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod |
| TWI260321B (en) | 1999-09-22 | 2006-08-21 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| SE9904413D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | Comminuted form |
| AU773777B2 (en) | 1999-12-03 | 2004-06-03 | Astrazeneca Ab | Crystalline form of (S)-2 ethoxy-3-(4-(2-(4-methanesulfonyloxyphenyl) ethoxy) phenyl) propanoic acid |
| EP2055302B1 (de) | 2000-03-31 | 2014-09-10 | Royalty Pharma Collection Trust | Verfahren zur Verbesserung der Langerhans'-Inselsignalisierung in Diabetes mellitus und zu dessen Prävention |
| EA004244B1 (ru) | 2000-04-25 | 2004-02-26 | Киорин Фармасьютикал Ко., Лтд. | Новый стабильный кристалл производного тиазолидиндиона и способ его получения |
| DK1277736T3 (da) | 2000-04-28 | 2007-10-01 | Asahi Kasei Pharma Corp | Hidtil ukendte bicykliske forbindelser |
| AU5959201A (en) | 2000-05-11 | 2001-11-20 | Bristol Myers Squibb Co | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| AU2001264977B2 (en) | 2000-05-30 | 2005-04-14 | Merck & Co., Inc. | Melanocortin receptor agonists |
| EE200200634A (et) | 2000-06-09 | 2004-04-15 | Aventis Pharma Deutschland Gmbh | Atsüülfenüülkarbamiidi derivaadid, nende saamine ja kasutamine veresuhkrut alandava ravimi valmistamiseks ning neid sisaldav ravim |
| TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
| DK1345895T3 (da) | 2000-12-21 | 2007-05-07 | Sanofi Aventis Deutschland | Hidtil ukendt diphenylazetidioner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse til behandling af lipidstofskifteforstyrrelser |
| WO2002067912A2 (en) | 2001-02-22 | 2002-09-06 | Smithkline Beecham Corporation | Method for treating ppar gamma mediated diseases or conditions |
| DE10112768A1 (de) | 2001-03-16 | 2002-09-19 | Merck Patent Gmbh | Phenylderivate 3 |
| GB0111523D0 (en) | 2001-05-11 | 2001-07-04 | Glaxo Group Ltd | Chemical compounds |
| PE20021091A1 (es) | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| DE10154689A1 (de) | 2001-11-09 | 2003-05-22 | Probiodrug Ag | Substituierte Aminoketonverbindungen |
| MXPA04001850A (es) | 2001-08-31 | 2004-06-15 | Aventis Pharma Gmbh | Derivados de diarilcicloalquilo, procedimientos para su preparacion y su utilizacion como agentes activadores de ppar. |
| WO2003043997A1 (en) * | 2001-11-15 | 2003-05-30 | Eli Lilly And Company | Peroxisome proliferator activated receptor alpha agonists |
| DE10215908B4 (de) | 2002-04-11 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel |
| DE10215907A1 (de) | 2002-04-11 | 2003-11-06 | Aventis Pharma Gmbh | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| DE10225635C1 (de) | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
| US7217727B2 (en) | 2003-04-01 | 2007-05-15 | Eli Lilly And Company | Phospholipase inhibitors |
| WO2004094394A1 (en) | 2003-04-01 | 2004-11-04 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
| DE102004005172A1 (de) | 2004-02-02 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase |
| EP1931660B1 (de) * | 2005-09-29 | 2012-08-01 | Sanofi | Phenyl-[1,2,4]-oxadiazol-5-on-derivate mit phenylgruppe, verfahren zu deren darstellung und deren verwendung als arzneimittel |
-
2004
- 2004-04-01 EP EP04007879A patent/EP1586573B1/de not_active Expired - Fee Related
- 2004-04-01 DE DE602004004631T patent/DE602004004631D1/de not_active Expired - Lifetime
-
2005
- 2005-02-17 GT GT200500028A patent/GT200500028A/es unknown
- 2005-03-19 SI SI200530778T patent/SI1740583T1/sl unknown
- 2005-03-19 DK DK05716233T patent/DK1740583T3/da active
- 2005-03-19 ES ES05716233T patent/ES2329484T3/es active Active
- 2005-03-19 EP EP05716233A patent/EP1740583B1/de active Active
- 2005-03-19 RU RU2006138498/04A patent/RU2374243C2/ru not_active IP Right Cessation
- 2005-03-19 AT AT05716233T patent/ATE435225T1/de not_active IP Right Cessation
- 2005-03-19 PT PT05716233T patent/PT1740583E/pt unknown
- 2005-03-19 BR BRPI0509517-4A patent/BRPI0509517A/pt not_active IP Right Cessation
- 2005-03-19 EP EP09005458A patent/EP2083006A1/de not_active Withdrawn
- 2005-03-19 CA CA002561627A patent/CA2561627A1/en not_active Abandoned
- 2005-03-19 AU AU2005231916A patent/AU2005231916A1/en not_active Abandoned
- 2005-03-19 DE DE602005015204T patent/DE602005015204D1/de active Active
- 2005-03-19 WO PCT/EP2005/002950 patent/WO2005097786A1/en active Application Filing
- 2005-03-19 RS RSP-2009/0391A patent/RS51186B/sr unknown
- 2005-03-19 CN CN200580010743A patent/CN100582104C/zh not_active Expired - Fee Related
- 2005-03-19 JP JP2007505433A patent/JP2007530612A/ja not_active Abandoned
- 2005-03-19 PL PL05716233T patent/PL1740583T3/pl unknown
- 2005-03-19 UA UAA200611486A patent/UA84203C2/ru unknown
- 2005-03-19 KR KR1020067020503A patent/KR20060135857A/ko not_active Application Discontinuation
- 2005-03-22 PE PE2005000323A patent/PE20060323A1/es not_active Application Discontinuation
- 2005-03-30 DO DO2005000051A patent/DOP2005000051A/es unknown
- 2005-03-30 TW TW094109908A patent/TW200602342A/zh unknown
- 2005-03-30 AR ARP050101221A patent/AR050576A1/es not_active Application Discontinuation
- 2005-03-31 MY MYPI20051461A patent/MY142431A/en unknown
- 2005-04-01 PA PA20058628701A patent/PA8628701A1/es unknown
- 2005-04-01 SV SV2005002071A patent/SV2006002071A/es not_active Application Discontinuation
- 2005-04-01 UY UY28837A patent/UY28837A1/es unknown
-
2006
- 2006-08-15 ZA ZA200606870A patent/ZA200606870B/en unknown
- 2006-08-24 CR CR8572A patent/CR8572A/es not_active Application Discontinuation
- 2006-09-13 IL IL178056A patent/IL178056A0/en unknown
- 2006-09-26 US US11/535,266 patent/US20070179191A1/en not_active Abandoned
- 2006-09-29 MA MA29354A patent/MA28495B1/fr unknown
- 2006-09-29 TN TNP2006000317A patent/TNSN06317A1/en unknown
- 2006-09-29 EC EC2006006892A patent/ECSP066892A/es unknown
- 2006-10-31 NO NO20064981A patent/NO20064981L/no not_active Application Discontinuation
-
2007
- 2007-07-31 HK HK07108322.5A patent/HK1100408A1/xx not_active IP Right Cessation
-
2008
- 2008-06-05 US US12/133,408 patent/US20080262052A1/en not_active Abandoned
- 2008-06-05 US US12/133,405 patent/US7709509B2/en not_active Expired - Fee Related
-
2009
- 2009-09-16 CY CY20091100958T patent/CY1109370T1/el unknown
- 2009-09-16 HR HR20090493T patent/HRP20090493T1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE435225T1 (de) | Oxadiazolonderivate als ppar-delta-agonisten | |
| ATE504559T1 (de) | Arylanilinderivate als agonisten des beta2- adrenergen rezeptors | |
| ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
| DE602006015607D1 (de) | Thiazol-4-carboxamid-derivate als mglur5-antagonisten | |
| ATE487719T1 (de) | Xanthinderivate als selektive hm74a-agonisten | |
| ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
| ATE420088T1 (de) | Chinolinoncarbonsäureamidverbindungen als 5-ht4- rezeptoragonisten | |
| ATE479676T1 (de) | Als antikoagulanzien verwendbare phenylglycinamid-derivate | |
| DE602006003628D1 (de) | Purinderivate als a2a-rezeptoragonisten | |
| DE602006007563D1 (de) | Agonisten | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
| ATE540935T1 (de) | Chinazolinderivate | |
| ATE549350T1 (de) | Neuropeptid-2-rezeptor-agonisten | |
| DE602006019624D1 (de) | Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| ATE486874T1 (de) | Purinonderivate als hm74a-agonisten | |
| DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
| ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
| ATE537149T1 (de) | Sulfonyl-pyrazolinyl-1-carboxamidinderivate als 5-ht6-antagonisten | |
| ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
| DK1971588T3 (da) | Tiglien-3-onderivater | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| ATE535523T1 (de) | Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten | |
| DE602004025215D1 (de) | Tastsonde |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1740583 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1740583 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |